FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast CancerByQuincy AttobrahJune 24th 2026
FDA Expands Tecelera Approval to Include Patients as Young as 12 With Advanced Synovial SarcomaByQuincy AttobrahJune 23rd 2026
